Skip to content

Celcuity CELC Free cash flow yield

Free cash flow yield at other companies

Eli Lilly logo
Eli LillyLLY
1.4%+0.9pp
Gilead Sciences logo
Gilead SciencesGILD
5.9%-1.1pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-3.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-16.1%-5.8pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-4.6%-2.1pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-4.8%-2.3pp

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on trailing twelve months.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's free cash flow yield?
Celcuity (CELC) reported free cash flow yield of -3.1% in Q1 2026.
How has Celcuity's free cash flow yield changed year-over-year?
Celcuity's free cash flow yield increased by 88.5% year-over-year, from -27.3% to -3.1%.
What is the long-term trend for Celcuity's free cash flow yield?
Over 5 years (2020 to 2025), Celcuity's free cash flow yield has grown at a -8.9% compound annual growth rate (CAGR), from -5.3% to -3.3%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.